Texas uni loses bid to shield cancer vaccine patents from IPRs
18-02-2021
Texas uni wants Supreme Court to settle state sovereignty rules
12-03-2020
f11photo / Shutterstock.com
The result of the sovereign immunity bid mirrored previous cases but we did learn something about the opinions of Justices on the issue, says Gary Frischling of Milbank.
The denial of the petition for panel rehearing or en banc rehearing in Board of Regents of the University of Texas System v Baylor College of Medicine is not surprising.
The original panel opinion followed, with limited discussion, the earlier University of Minnesota decision where panel (Justices Dyk, Wallach and Hughes) held state sovereign immunity did not apply to inter partes reviews (IPRs) because an IPR represents the US government’s reconsideration of its initial patent grant.
The Univ of Minn panel found its reasoning to be in line with St Regis Band of Mohawk v Mylan (Justices Dyk, Moore and Reyna), which held, on similar grounds, that tribal sovereign immunity did not apply to IPRs.
To continue reading this article and to access our full archive, digital magazines and special reports you will need a subscription.
Start a subscription today to access the LSIPR website
If you have already subscribed please login.
For multi-user price options, or to check if your company has an existing subscription we can add you into, please email Atif at achoudhury@newtonmedia.co.uk
If you have any technical issues please email tech support.
For access to the complete website and archive choose '12 MONTH SUBSCRIPTION'. For a free, two-week trial select ‘TWO WEEK FREE TRIAL’.
Patents, sovereign immunity, university, University of Texas, en banc, inter partes review
